Prince Khalid Al-Faisal reviews government performance during Ramadan in Makkah
JEDDAH – Emir of Makkah Prince Khalid Al-Faisal received his deputy, Prince Saud bin Mishal bin Abdulaziz, who presented a report detailing the performance of government agencies during the holy month of Ramadan.
During the meeting, Prince Khalid commended the work of various entities involved in facilitating services for worshippers at the Grand Mosque.
He praised their efforts in ensuring smooth operations and supporting visitors in performing their religious rituals.
Authorities in Makkah implemented several measures throughout Ramadan to manage crowds, enhance security, and improve services at the Grand Mosque. The discussion highlighted the importance of continued coordination to maintain operational efficiency during the peak season.
On Friday, the General Authority for the Care of the Grand Mosque and the Prophet's Mosque launched its operational plan for the last ten days of Ramadan, a period expected to witness the highest influx of worshippers.The plan includes a wide range of services such as preparing prayer areas with clean carpets, ensuring sanitation and cleanliness, carrying out regular fumigation, and maintaining a steady supply of Zamzam water. It also covers environmental protection services, restroom maintenance, and the provision of carts for those in need.To support these efforts, a monitoring and reporting system has been activated to oversee crowd movement, maintain order, and ensure a smooth and comfortable experience for all visitors.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Saudi Gazette
9 hours ago
- Saudi Gazette
Dr. Fahd Toonsi appointed chief of Saudi Red Sea Authority
Saudi Gazette report RIYADH — Dr. Fahd Toonsi, advisor at the Royal Court, has been appointed chairman of the Board of Directors of the Saudi Red Sea Authority (SRSA). A royal approval was issued in this regard, the Saudi Press Agency reported. The SRSA Board of Directors thanked Crown Prince and Prime Minister Mohammed bin Salman for the appointment. 'The approval comes as an extension of the continuous support provided by the wise leadership to enhance the Kingdom's position on the world map and enable a thriving coastal tourism economy,' the board said in a statement. On his part, Toonsi expressed his gratitude to Minister of Tourism Ahmed Al-Khateeb for the efforts made while he was chairing the SRSA Board of Directors in the past, and the tangible achievements that contributed to achieving the goals of the Kingdom's Vision 2030. Dr. Toonsi earlier served as secretary general of SRSA, which is responsible for overseeing tourism development on Saudi Arabia's west coast, including the Red Sea Project.
Saudi Gazette
4 days ago
- Saudi Gazette
SFDA publishes guidelines for travelers to obtain clearance permit for controlled drugs
Saudi Gazette report RIYADH — The Saudi Food and Drug Authority (SFDA) has outlined the procedures for obtaining a clearance permit for controlled drugs containing narcotics and psychotropic substances in the possession of passengers arriving in or departing from Saudi Arabia. This reinforces SFDA's commitment to facilitating patients' travel and ensuring a smoother journey while maintaining safety standards. SFDA confirms that all information related to controlled drug permits is available through its Controlled Drug System (CDS) at Travelers can now easily apply for a permit through the CDS platform by creating a personal account, submitting an electronic clearance permit request with the patient's details and trip information, and uploading supporting documents like a prescription, medical report, and proof of identity. Travelers can also add multiple medications by providing accurate details, including the trade name, active ingredient, drug concentration, dosage form, and quantity or pack size. Applicants must include documents that prove the medical need for the medication, whether it is for the traveler or another patient. The applicant must agree to the terms and conditions, and then submit the application. Travelers can also track the status of the application, which is clearly classified as "Submitted," "Completed," "Rejected," or "Incomplete." The applicant can take the printout of the permit once the application is completed. This guideline highlights SFDA's role in regulating the entry and exit of controlled drugs, protecting patient rights, and preventing misuse. It provides a convenient and secure way for traveling patients to get the clearances they need, allowing them to submit requests at any time and from any location, which eliminates the need for additional procedures. For a step-by-step guide on how to obtain a clearance permit for controlled drugs, travelers can refer to the User Manual for the Traveler Clearance Permit of Controlled Drugs on SFDA website:
Saudi Gazette
4 days ago
- Saudi Gazette
SFDA publishes guidelines for travelers to obtain clearance permit for controlled drugs
Saudi Gazette report RIYADH — The Saudi Food and Drug Authority (SFDA) has outlined the procedures for obtaining a clearance permit for controlled drugs containing narcotics and psychotropic substances in the possession of passengers arriving in or departing from Saudi Arabia. This reinforces SFDA's commitment to facilitating patients' travel and ensuring a smoother journey while maintaining safety standards. SFDA confirms that all information related to controlled drug permits is available through its Controlled Drug System (CDS) at Travelers can now easily apply for a permit through the CDS platform by creating a personal account, submitting an electronic clearance permit request with the patient's details and trip information, and uploading supporting documents like a prescription, medical report, and proof of identity. Travelers can also add multiple medications by providing accurate details, including the trade name, active ingredient, drug concentration, dosage form, and quantity or pack size. Applicants must include documents that prove the medical need for the medication, whether it is for the traveler or another patient. The applicant must agree to the terms and conditions, and then submit the application. Travelers can also track the status of the application, which is clearly classified as "Submitted," "Completed," "Rejected," or "Incomplete." The applicant can take the printout of the permit once the application is completed. This guideline highlights SFDA's role in regulating the entry and exit of controlled drugs, protecting patient rights, and preventing misuse. It provides a convenient and secure way for traveling patients to get the clearances they need, allowing them to submit requests at any time and from any location, which eliminates the need for additional procedures. For a step-by-step guide on how to obtain a clearance permit for controlled drugs, travelers can refer to the User Manual for the Traveler Clearance Permit of Controlled Drugs on SFDA website:
